NEW YORK (GenomeWeb News) – Bruker Daltonics and Boston University's Mass Spectrometry Resource plan to collaborate to apply high performance ion trap mass spectrometry and Fourier transform mass spec to glycomics and proteomics research, Bruker announced today.

Catherine Costello, director of the Boston University School of Medicine's Center for Biomedical Mass Spectrometry, and her colleagues plan to use Bruker's solariX FTMS with a 12 Tesla magnet, with electron transfer dissociation and electron capture dissociation capabilities, for their proteomics and glycomics studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.